OUR ATTORNEYS
ATTORNEYS
160 LAWYERS
Tal S. Eliasaf | Partner
Tal Eliasaf is the Managing Partner of the firm and a senior member of the M&A Department. His practice focuses on mergers & acquisitions, private equity transactions, venture capital investments, corporate law, commercial transactions and securities law, with a particular emphasis on technology companies.

Tal joined Naschitz Brandes Amir as an intern in 2000 and was elected a partner at the end of 2008. From 2006 to 2007, Tal worked as an associate in the M&A group of Davis Polk & Wardwell in New York. From 2012 to 2014 Tal served as a member of the firm’s first executive committee. In 2017 he was elected Managing Partner of the firm.

Tal has extensive M&A, venture capital and private equity experience. His deep expertise lies in structuring and negotiating complex cross-border transactions and commercial agreements, leveraged buyouts and going private transactions. Tal's vast deal experience spans across many industry sectors, including significant depth in the Hi-Tech industry. From 2009 to 2012 he served as a member of the Hi-Tech Committee of the Israeli Bar Association.
Education
LL.B. (cum laude), Interdisciplinary Center of Herzliya (2000)
B.A in Business Administration (cum laude), Interdisciplinary Center of Herzliya (2000)
LL.M. (summa cum laude), Tel Aviv University, in collaboration with the University of California, Berkeley (2007)
Admission
Israel (2001)
Languages
Hebrew
English
Representative experience
Tal's clients include public and private companies in a broad range of industries. Notable representations include:

- The management of the NSO Group, a leading cyber-technology company, in the $800 million management buyout from Francisco Partners

- EZchip Semiconductor (NASDAQ-listed) in its $811 million merger with Mellanox Technologies (NASDAQ-listed)

- Selling shareholders, headed by FIMI Opportunity Funds, in the sale of a 22% stake in Ormat Technologies (NYSE-listed) to Japan-based Orix Corporation for approximately $630 million

- Midea Group (Shenzhen–listed) in its NIS 650 million acquisition of Servotronix Motion Control

- FIMI in its $150 million acquisition of a controlling stake in Ormat Industries (NYSE-listed)

- EZchip Semiconductor (NASDAQ-listed) in its $130 million acquisition of US-based Tilera Corporation

- Amitim Pension Fund in its NIS 450 million financing for the acquisition of Bezeq

- Tami 4 in its NIS 320 million sale to H2Q-Strauss Group

- KUKA Deutschland GmbH (Frankfurt–listed) in its acquisition of a 13% stake in SMC

- Diskin Advanced Technologies in its transaction with Volkswagen AG (Frankfurt–listed)

- US Quartz Products in its sale to CesarStone Sdot Yam (NASDAQ-listed)

- Keren Haal in its NIS 100 million sale to Psagot Investment House

- Ness Technologies (NASDAQ-listed) in the sale to SAP AG (Frankfurt–listed)

- Checkpoint (NASDAQ-listed) in its acquisition of a division of Nokia – Siemens

- Curve in its $55 million Round B equity financing

- IceCure in its $13 million transaction with Terumo Corporation (Tokyo-listed)

- Canabliss in its acquisition by Together Pharma (Tel Aviv-listed)
Contact Information:
Tel. +972-3-623-6000
Fax. +972-3-623-6003
Tal S. Eliasaf | Partner
Tal Eliasaf is the Managing Partner of the firm and a senior member of the M&A Department. His practice focuses on mergers & acquisitions, private equity transactions, venture capital investments, corporate law, commercial transactions and securities law, with a particular emphasis on technology companies.

Tal joined Naschitz Brandes Amir as an intern in 2000 and was elected a partner at the end of 2008. From 2006 to 2007, Tal worked as an associate in the M&A group of Davis Polk & Wardwell in New York. From 2012 to 2014 Tal served as a member of the firm’s first executive committee. In 2017 he was elected Managing Partner of the firm.

Tal has extensive M&A, venture capital and private equity experience. His deep expertise lies in structuring and negotiating complex cross-border transactions and commercial agreements, leveraged buyouts and going private transactions. Tal's vast deal experience spans across many industry sectors, including significant depth in the Hi-Tech industry. From 2009 to 2012 he served as a member of the Hi-Tech Committee of the Israeli Bar Association.
Education
LL.B. (cum laude), Interdisciplinary Center of Herzliya (2000)
B.A in Business Administration (cum laude), Interdisciplinary Center of Herzliya (2000)
LL.M. (summa cum laude), Tel Aviv University, in collaboration with the University of California, Berkeley (2007)
Admission
Israel (2001)
Languages
Hebrew
English
Representative experience
Tal's clients include public and private companies in a broad range of industries. Notable representations include:

- The management of the NSO Group, a leading cyber-technology company, in the $800 million management buyout from Francisco Partners

- EZchip Semiconductor (NASDAQ-listed) in its $811 million merger with Mellanox Technologies (NASDAQ-listed)

- Selling shareholders, headed by FIMI Opportunity Funds, in the sale of a 22% stake in Ormat Technologies (NYSE-listed) to Japan-based Orix Corporation for approximately $630 million

- Midea Group (Shenzhen–listed) in its NIS 650 million acquisition of Servotronix Motion Control

- FIMI in its $150 million acquisition of a controlling stake in Ormat Industries (NYSE-listed)

- EZchip Semiconductor (NASDAQ-listed) in its $130 million acquisition of US-based Tilera Corporation

- Amitim Pension Fund in its NIS 450 million financing for the acquisition of Bezeq

- Tami 4 in its NIS 320 million sale to H2Q-Strauss Group

- KUKA Deutschland GmbH (Frankfurt–listed) in its acquisition of a 13% stake in SMC

- Diskin Advanced Technologies in its transaction with Volkswagen AG (Frankfurt–listed)

- US Quartz Products in its sale to CesarStone Sdot Yam (NASDAQ-listed)

- Keren Haal in its NIS 100 million sale to Psagot Investment House

- Ness Technologies (NASDAQ-listed) in the sale to SAP AG (Frankfurt–listed)

- Checkpoint (NASDAQ-listed) in its acquisition of a division of Nokia – Siemens

- Curve in its $55 million Round B equity financing

- IceCure in its $13 million transaction with Terumo Corporation (Tokyo-listed)

- Canabliss in its acquisition by Together Pharma (Tel Aviv-listed)